EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pharmacology, prevalence in Germany, and analytical data of cyclobutylmethyl‐ and norbornylmethyl‐type synthetic cannabinoid receptor agonists

Benedikt Pulver iD, Jan Riedel, Torsten Schönberger iD, Sebastian Halter, Tobias Lucas iD, Till Opatz iD, Katharina Elisabeth Grafinger iD, Martin Scheu, Annette Zschiesche, Michael Pütz iD, Klaus Pützer, Folker Westphal und 1 weitere

Drug Testing and Analysis · 2023

DOI: 10.1002/dta.3427 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Testing and Analysis, 2023. Verfasst von Benedikt Pulver und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Forensic Medicine, Forensic Toxicology, Medical Center - University of Freiburg, Freiburg, Germany. Hauptthemen laut MEDLINE: Cannabinoid Receptor Agonists, Indazoles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Internal Security Fund of the European Union, Swiss National Science Foundation, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Synthetic cannabinoid receptor agonists (SCRAs) are distributed on the drug market to produce THC‐like effects while evading routine drug testing and legislation. The cyclobutylmethyl (CBM) and norbornylmethyl (NBM) side chain specifically circumvented the German legislation and led to the emergence of exploratory SCRAs in 2019–2021. The NBM SCRAs were detected post‐amendment of the new psychoactive substances act in 2020, which scheduled all CBM SCRAs. All six SCRAs are full agonists at the cannabinoid receptor 1 compared with Δ 9 ‐tetrahydrocannabinol and CP‐55,940. The CBM SCRAs showed binding affinities of K i : 29.4–0.65 n m and potencies of EC 50 : 483–40.1 n m (CBMICA

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cannabinoid Receptor AgonistsIndazolesPrevalenceGermanyReceptor, Cannabinoid, CB1Cannabinoids

Stichwörter der Autor:innen

new psychoactive substancesorganic synthesispharmacologyprevalencesynthetic cannabinoid receptor agonists

Substanzen

Cannabinoid Receptor AgonistsIndazolesReceptor, Cannabinoid, CB1Cumyl-CBMICACannabinoids

Autor:innen und Institutionen

  • Institute of Forensic Medicine, Forensic Toxicology, Medical Center - University of Freiburg, Freiburg, Germany.
  • Hermann Staudinger Graduate School, University of Freiburg, Freiburg, Germany.
  • State Bureau of Criminal Investigation Schleswig-Holstein, Forensic Science Institute, Kiel, Germany.
  • Federal Criminal Police Office, Forensic Science Institute, Wiesbaden, Germany.
  • Department of Chemistry, Johannes Gutenberg University, Mainz, Germany.
  • Douane Laboratorium, Amsterdam, The Netherlands.

ORCID-Profile: Benedikt Pulver, Torsten Schönberger, Tobias Lucas, Till Opatz, Katharina Elisabeth Grafinger, Michael Pütz, Volker Auwärter

Förderung

  • Internal Security Fund of the European Union
  • Swiss National Science Foundation
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Zitieren

APA

Pulver, B., Riedel, J., Schönberger, T., Halter, S., Lucas, T., Opatz, T., Grafinger, K. E., Scheu, M., Zschiesche, A., Pütz, M., Pützer, K., Westphal, F., & Auwärter, V. (2023). Pharmacology, prevalence in Germany, and analytical data of cyclobutylmethyl‐ and norbornylmethyl‐type synthetic cannabinoid receptor agonists. Drug Testing and Analysis. https://doi.org/10.1002/dta.3427

Vancouver

Pulver B, Riedel J, Schönberger T, Halter S, Lucas T, Opatz T, et al. Pharmacology, prevalence in Germany, and analytical data of cyclobutylmethyl‐ and norbornylmethyl‐type synthetic cannabinoid receptor agonists. Drug Testing and Analysis. 2023. doi:10.1002/dta.3427

BibTeX
@article{Pulver2023,
  author = {Pulver, Benedikt and Riedel, Jan and Schönberger, Torsten and Halter, Sebastian and Lucas, Tobias and Opatz, Till and Grafinger, Katharina Elisabeth and Scheu, Martin and Zschiesche, Annette and Pütz, Michael and Pützer, Klaus and Westphal, Folker and Auwärter, Volker},
  title = {Pharmacology, prevalence in Germany, and analytical data of cyclobutylmethyl‐ and norbornylmethyl‐type synthetic cannabinoid receptor agonists},
  journal = {Drug Testing and Analysis},
  year = {2023},
  doi = {10.1002/dta.3427}
}
Kostenlos starten →